High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission
暂无分享，去创建一个
[1] V. Chopra,et al. 74. Empiric Antibiotic Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study , 2020 .
[2] S. Shiau,et al. Risk Factors and Outcomes of Hospitalized Patients with Severe COVID-19 and Secondary Bloodstream Infections: A Multicenter, Case-Control Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] D. Busch,et al. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship , 2020, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.
[4] L. Westblade,et al. Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City , 2020, Journal of Clinical Microbiology.
[5] A. Galecki,et al. A targeted infection prevention intervention in nursing home residents with indwelling devices: a randomized clinical trial. , 2015, JAMA internal medicine.
[6] A. Cheng,et al. Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control study , 2014, BMC Infectious Diseases.